640 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by Empirical Asset Management LLC

Empirical Asset Management LLC purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 3rd quarter, Holdings Channel reports. The institutional investor purchased 640 shares of the biotechnology company’s stock, valued at approximately $256,000.

A number of other large investors have also added to or reduced their stakes in AXON. V Square Quantitative Management LLC increased its holdings in Axon Enterprise by 22.1% during the 4th quarter. V Square Quantitative Management LLC now owns 1,750 shares of the biotechnology company’s stock valued at $452,000 after purchasing an additional 317 shares during the period. Virtu Financial LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $439,000. EP Wealth Advisors LLC bought a new stake in Axon Enterprise in the fourth quarter valued at $323,000. American International Group Inc. increased its position in Axon Enterprise by 1.1% during the 4th quarter. American International Group Inc. now owns 19,924 shares of the biotechnology company’s stock valued at $5,147,000 after purchasing an additional 208 shares during the period. Finally, Goldman Sachs Group Inc. raised its holdings in Axon Enterprise by 110.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 276,011 shares of the biotechnology company’s stock worth $71,302,000 after purchasing an additional 144,568 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

AXON stock opened at $437.98 on Tuesday. The stock’s 50 day simple moving average is $381.46 and its 200 day simple moving average is $328.45. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 12-month low of $199.29 and a 12-month high of $440.89. The stock has a market capitalization of $33.10 billion, a PE ratio of 115.56, a price-to-earnings-growth ratio of 11.49 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same period in the prior year, the company posted $0.80 earnings per share. The company’s quarterly revenue was up 34.5% on a year-over-year basis. As a group, research analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Barclays boosted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird increased their target price on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Bank of America began coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective for the company. Finally, JMP Securities upped their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $365.38.

Insider Activity

In related news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the transaction, the chief financial officer now owns 98,825 shares in the company, valued at $37,449,733.75. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 370,172 shares of company stock valued at $136,562,182 in the last 90 days. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.